AXPH Stock Overview
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets and distributes generic forms of human and animal health products in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Alexandria Co. For Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م183.63 |
| 52 Week High | ج.م187.00 |
| 52 Week Low | ج.م116.01 |
| Beta | 0.027 |
| 1 Month Change | 22.07% |
| 3 Month Change | 19.23% |
| 1 Year Change | 62.02% |
| 3 Year Change | 33.57% |
| 5 Year Change | 66.94% |
| Change since IPO | 463.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| AXPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 17.5% | 3.7% | -2.1% |
| 1Y | 62.0% | 21.8% | 76.8% |
Return vs Industry: AXPH exceeded the EG Pharmaceuticals industry which returned 25.7% over the past year.
Return vs Market: AXPH underperformed the EG Market which returned 79.8% over the past year.
Price Volatility
| AXPH volatility | |
|---|---|
| AXPH Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in EG Market | 9.9% |
| 10% least volatile stocks in EG Market | 4.3% |
Stable Share Price: AXPH is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: AXPH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Mahmoud Rizk | https://www.alexcopharma.net |
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets and distributes generic forms of human and animal health products in Egypt. The company also offers medical appliances. The company was incorporated in 1962 and is based in Alexandria, Egypt.
Alexandria Co. For Pharmaceuticals & Chemical Industries Fundamentals Summary
| AXPH fundamental statistics | |
|---|---|
| Market Cap | ج.م918.15m |
| Earnings (TTM) | ج.م134.93m |
| Revenue (TTM) | ج.م1.27b |
6.8x
P/E Ratio0.7x
P/S RatioIs AXPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.27b |
| Cost of Revenue | ج.م990.26m |
| Gross Profit | ج.م284.08m |
| Other Expenses | ج.م149.15m |
| Earnings | ج.م134.93m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.99 |
| Gross Margin | 22.29% |
| Net Profit Margin | 10.59% |
| Debt/Equity Ratio | 1.5% |
How did AXPH perform over the long term?
See historical performance and comparison